Paper42377611
Melatonin for age-related vascular diseases: mechanistic rationale, translational barriers, and clinical prospects.
Khatami S and 5 others. Mol Biol Rep, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Melatonin for age-related vascular diseases: mechanistic rationale, translational barriers, and clinical prospects. Papers, record 42377611. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42377611
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Melatonin for age-related vascular diseases: mechanistic rationale, translational barriers, and clinical prospects.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Melatonin | Major topic |
| Vascular Diseases | Major topic |
| Aging | Major topic |
| Humans | |
| Animals | |
| Oxidative Stress | |
| Circadian Rhythm | |
| Antioxidants |
Source PubMed
References118
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34924765 | Melatonin Alleviates Age-Associated Endothelial Injury of Atherosclerosis via Regulating Telomere Function. | J Inflamm Res | 2021 | https://conductscience.org/library/papers/34924765 | PubMed |
| 2 | 26514204 | MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective. | Annu Rev Pharmacol Toxicol | 2016 | https://conductscience.org/library/papers/26514204 | PubMed |
| 3 | 30661353 | Melatonin Inhibits in Vitro Smooth Muscle Cell Inflammation and Proliferation and Atherosclerosis in Apolipoprotein E-Deficient Mice. | J Agric Food Chem | 2019 | https://conductscience.org/library/papers/30661353 | PubMed |
| 4 | 34917024 | Research Hot Spots and Trends on Melatonin From 2000 to 2019. | Front Endocrinol (Lausanne) | 2021 | https://conductscience.org/library/papers/34917024 | PubMed |
| 5 | 28538666 | Melatonin Attenuates Pulmonary Hypertension in Chronically Hypoxic Rats. | Int J Mol Sci | 2017 | https://conductscience.org/library/papers/28538666 | PubMed |
| 6 | 30254716 | Melatonin Ameliorates the Progression of Atherosclerosis via Mitophagy Activation and NLRP3 Inflammasome Inhibition. | Oxid Med Cell Longev | 2018 | https://conductscience.org/library/papers/30254716 | PubMed |
| 7 | 31597622 | The Effects of Melatonin Supplementation on Parameters of Mental Health, Glycemic Control, Markers of Cardiometabolic Risk, and Oxidative Stress in Diabetic Hemodialysis Patients: A Randomized, Double-Blind, Placebo-Controlled Trial. | J Ren Nutr | 2020 | https://conductscience.org/library/papers/31597622 | PubMed |
| 8 | 38375039 | Systematic review of melatonin in cerebral ischemia-reperfusion injury: critical role and therapeutic opportunities. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38375039 | PubMed |
| 9 | 38706348 | Therapeutic Effects of Melatonin in the Regulation of Ferroptosis: A Review of Current Evidence. | Curr Drug Targets | 2024 | https://conductscience.org/library/papers/38706348 | PubMed |
| 10 | 29049001 | Effects of melatonin on mechanisms involved in hypertension using human umbilical vein endothelial cells. | J Toxicol Environ Health A | 2017 | https://conductscience.org/library/papers/29049001 | PubMed |
| 11 | 16678784 | Melatonin as antioxidant, geroprotector and anticarcinogen. | Biochim Biophys Acta | 2006 | https://conductscience.org/library/papers/16678784 | PubMed |
| 12 | 25736256 | Melatonin reduces oxidative stress and improves vascular function in pulmonary hypertensive newborn sheep. | J Pineal Res | 2015 | https://conductscience.org/library/papers/25736256 | PubMed |
| 13 | 28585236 | Melatonin in regulation of inflammatory pathways in rheumatoid arthritis and osteoarthritis: involvement of circadian clock genes. | Br J Pharmacol | 2018 | https://conductscience.org/library/papers/28585236 | PubMed |
| 14 | 38041171 | Melatonin alleviates pyroptosis by regulating the SIRT3/FOXO3α/ROS axis and interacting with apoptosis in Atherosclerosis progression. | Biol Res | 2023 | https://conductscience.org/library/papers/38041171 | PubMed |
| 15 | 28478022 | The preventive and curative effects of melatonin against abdominal aortic aneurysm in rats. | J Vasc Surg | 2018 | https://conductscience.org/library/papers/28478022 | PubMed |
| 16 | 22109832 | Aging and vascular dysfunction: beneficial melatonin effects. | Age (Dordr) | 2013 | https://conductscience.org/library/papers/22109832 | PubMed |
| 17 | 35402542 | Melatonin Attenuates Dasatinib-Aggravated Hypoxic Pulmonary Hypertension via Inhibiting Pulmonary Vascular Remodeling. | Front Cardiovasc Med | 2022 | https://conductscience.org/library/papers/35402542 | PubMed |
| 18 | 39312673 | Age-Disturbed Vascular Extracellular Matrix Links to Abdominal Aortic Aneurysms. | J Gerontol A Biol Sci Med Sci | 2024 | https://conductscience.org/library/papers/39312673 | PubMed |
| 19 | 31774487 | Melatonin inhibits inflammasome-associated activation of endothelium and macrophages attenuating pulmonary arterial hypertension. | Cardiovasc Res | 2020 | https://conductscience.org/library/papers/31774487 | PubMed |
| 20 | 35721030 | Melatonin as an Anti-Aging Therapy for Age-Related Cardiovascular and Neurodegenerative Diseases. | Front Aging Neurosci | 2022 | https://conductscience.org/library/papers/35721030 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42939810 | Redox Chronobiology of Secondary Hyperparathyroidism in Chronic Kidney Disease: Exploring the Circadian-Melatonin-PTH Axis. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42939810 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42377611
GET https://conductscience.org/api/papers/v1/42377611/references?page=2